MENU

Why this big bank became a major shareholder of NIB Holdings Limited

There isn’t a bigger vote of confidence for an ASX-listed company than Commonwealth Bank of Australia (ASX: CBA) becoming a major shareholder.

NIB Holdings Limited (ASX: NHF) is one of Australia’s largest private health insurers. Commonwealth Bank currently owns just over 5% of NIB shares and clearly believes in its long-term future.

NIB has done a good job of sweeping up a lot of the growth in the private health insurance sector in the last few years. In FY17 it grew its net policyholders in Australia by 3.8%. It grew its market share from 8.1% to 8.3%.

The private health insurance industry has come under pressure in recent times for how big the premium increases have been in recent years. This has been hard to swallow for policyholders when inflation and wage growth has been so low. In its Australian segment NIB grew its net margin to 6.4% from 6%, which shows it is making more profit on each dollar than it did before.

I think NIB could be a good long-term investment for a few different reasons.

NIB has shown it can very effectively grow the business, it is a well-run machine. In FY17 its underlying operating profit by 16.4%, which was on top of several years of good growth.

The government needs the private health insurance to succeed. The ageing demographics of Australia will lead to more patients going to public hospitals. If the private health industry and the government can encourage people into the private system that should save on the amount of hospital beds needed and the inevitable wait times in emergency waiting rooms & for non-urgent operations.

I like NIB as a healthcare option because it gives exposure to all the different health problems, rather than just one issue that other companies focus on, like Cochlear Limited (ASX: COH).

Foolish takeaway

The drop in share price of around 10% over the past week means that it’s currently trading at 23x FY18’s estimated earnings. I think this is a pretty good price to pay for NIB considering it could keep delivering decent growth for many years to come. But, sustained low premium growth could slow NIB down.

These top stocks would also be good additions to a portfolio instead of NIB.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. and NIB Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.